Advanced Search

Study Preview



Study Title and Description

Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.



Key Questions Addressed
1 Key Question 1. In adult women without preexisting breast cancer, what is the accuracy of risk assessment methods to identify women who could benefit from medications to reduce risk for primary breast cancer (e.g., clinical risk assessment models)? Key Question 1a. What is the optimal age at which to begin risk assessment to identify women who could benefit from medications to reduce risk for primary breast cancer? Key Question 1b. What is the optimal frequency of risk assessment to identify women who could benefit from medications to reduce risk for primary breast cancer?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia.
Author Boughey JC., Hartmann LC., Anderson SS., Degnim AC., Vierkant RA., Reynolds CA., Frost MH., Pankratz VS.
Country Mayo Clinic, Rochester, MN 55905, USA.
Year 2010
Numbers Pubmed ID: 20606088

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-4


Results & Comparisons

No Results found.